Matches in Wikidata for { <http://www.wikidata.org/entity/Q91922749> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q91922749 description "article scientifique publié en 2019" @default.
- Q91922749 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91922749 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91922749 description "scientific article published on 02 December 2019" @default.
- Q91922749 description "wetenschappelijk artikel" @default.
- Q91922749 description "наукова стаття, опублікована 2 грудня 2019" @default.
- Q91922749 name "Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy" @default.
- Q91922749 name "Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy" @default.
- Q91922749 type Item @default.
- Q91922749 label "Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy" @default.
- Q91922749 label "Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy" @default.
- Q91922749 prefLabel "Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy" @default.
- Q91922749 prefLabel "Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy" @default.
- Q91922749 P1433 Q91922749-6831CA44-35C6-40B7-AFF2-C15CE67F2325 @default.
- Q91922749 P1476 Q91922749-70167CE6-8614-42CA-84F9-FCCDCA478DFB @default.
- Q91922749 P2093 Q91922749-4C62F5E0-2A44-411D-962F-1B9443D59829 @default.
- Q91922749 P2093 Q91922749-52AA7A1C-7EC8-46DE-A485-1D2D5550A1AE @default.
- Q91922749 P2093 Q91922749-D60857FE-718D-4C4B-BD7D-AC6A349A11B4 @default.
- Q91922749 P304 Q91922749-21A854D9-1F6F-45BA-8BF3-6ED4B8E4CCA2 @default.
- Q91922749 P31 Q91922749-F8E3C112-A991-4545-8C8C-F10F313EF0FC @default.
- Q91922749 P356 Q91922749-BF33A1CB-6B56-4DB9-9F44-2DD19DAB06F5 @default.
- Q91922749 P478 Q91922749-BE024EAB-362B-49AC-967E-43FBF02405AB @default.
- Q91922749 P577 Q91922749-3105CDC0-E424-4A30-A663-5187A90F7908 @default.
- Q91922749 P698 Q91922749-F7067323-670A-4E21-B9CE-47B50527F9EF @default.
- Q91922749 P921 Q91922749-F65205D9-B157-486B-B8FA-FC5A99CBF5E5 @default.
- Q91922749 P356 J.CLINEURO.2019.105630 @default.
- Q91922749 P698 31830679 @default.
- Q91922749 P1433 Q15763519 @default.
- Q91922749 P1476 "Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy" @default.
- Q91922749 P2093 "Mitsugu Yanagidaira" @default.
- Q91922749 P2093 "Takanori Yokota" @default.
- Q91922749 P2093 "Yoichiro Nishida" @default.
- Q91922749 P304 "105630" @default.
- Q91922749 P31 Q13442814 @default.
- Q91922749 P356 "10.1016/J.CLINEURO.2019.105630" @default.
- Q91922749 P478 "189" @default.
- Q91922749 P577 "2019-12-02T00:00:00Z" @default.
- Q91922749 P698 "31830679" @default.
- Q91922749 P921 Q8285 @default.